Scarica l'app Stockscreener
0.3399
4.31%
-0.0153
Co Diagnostics Inc Borsa (CODX) Ultime notizie
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Co-Diagnostics Q1 2025 shows improved EPS and revenue decline - Investing.com Nigeria
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Stra - GuruFocus
Co-Diagnostics Q1 2025 Earnings Call Transcript - MarketBeat
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid Revenue ... - Yahoo Finance
Co-Diagnostics Reports Q1 2025 Financial Results - TipRanks
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates - MSN
Co-Diagnostics Inc Reports Q1 2025 Earnings: EPS Loss of $0.24 Beats Estimates, Revenue Falls Short at $0.1 Million - GuruFocus
Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results - The Manila Times
Examining the Future: Co-Diagnostics's Earnings Outlook - Nasdaq
Co-Diagnostics (NASDAQ:CODX) Stock Rating Upgraded by D Boral Capital - Defense World
D. Boral Capital Initiates Coverage of Co-Diagnostics (LSE:0A50) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Relea - GuruFocus
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast - GlobeNewswire
Co-Diagnostics Q1 2025 Earnings Coming May 8: Key Executive Team to Present Latest Financial Performance - Stock Titan
Stock Market Recap: Co-Diagnostics Inc (CODX) Concludes at 0.32, a -18.26 Surge/Decline - DWinneX
Co-Diagnostics (NASDAQ:CODX) Now Covered by Analysts at D. Boral Capital - Defense World
Co-Diagnostics expands sales agreement, adds Clear Street as agent By Investing.com - Investing.com Canada
Co-Diagnostics expands sales agreement, adds Clear Street as agent - Investing.com Australia
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
D. Boral Capital Initiates Coverage of Co-Diagnostics (CODX) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. - Seeking Alpha
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results - Seeking Alpha
Co-Diagnostics Inc (NASDAQ: CODX): Is This The Time To Buy? - Marketing Sentinel
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges - Investing.com Canada
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges By Investing.com - Investing.com South Africa
All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy - Yahoo Finance
Co-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa - MSN
Co-Diagnostics Earnings Call: Progress Amid Challenges - MSN
HC Wainwright Lowers Co-Diagnostics (NASDAQ:CODX) Price Target to $1.00 - Defense World
Co-Diagnostics, Inc. (CODX) Reports Q4 Loss, Misses Revenue Estimates - MSN
Co-Diagnostics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Co-Diagnostics sees revenue dip, losses deepen in Q4 2024 By Investing.com - Investing.com South Africa
Co-Diagnostics operating loss hits USD 40.1M in FY 24 - Medical Buyer
Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navi - GuruFocus
Co-Diagnostics Inc (CODX) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Co-Diagnostics Reports 2024 Financial Results and Strategic Progress - TipRanks
Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results - Lelezard
Co-Diagnostics Inc Reports $3.9 Million Revenue and $1.24 EPS Lo - GuruFocus
Co-Diagnostics earnings missed by $0.03, revenue fell short of estimates - Investing.com
Co-Diagnostics (CODX) Highlights 2024 Earnings and Strategic Dev - GuruFocus
Earnings call transcript: Co-Diagnostics sees revenue dip, losses deepen in Q4 2024 - Investing.com India
0.11%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):